Cannabis has it advantages so also it disadvantages. A rightful of the popular drug would result into its advantages to human. However, research shows a high percentage of people use it for the wrongful purpose most times, medically.
A drug reform group has slammed the Government for “maintaining cannabis has no medical uses” while allowing its export abroad.
The UK is the world’s largest producer and exporter of legal cannabis for medical and scientific use, according to a new report from a UN body.
The UK produced 95 tonnes of legal cannabis in 2016, more than double the total of the previous year, reveals the UN’s International Narcotics Control Board. This accounted for 44.9% of the world total.
The nearest competitor is Canada, with 80.7 tonnes.
Some 2.1 tonnes was exported from the UK, making it responsible for 67.7% of the world total, followed by the Netherlands (16.4%).
A drug policy reform lobby group has criticised the UK government, saying they have “consistently refused to allow medical cannabis in the UK on the basis that it has ‘no therapeutic value'”.
Steve Rolles, Transform’s senior policy analyst said: “It is scandalous and untenable for the UK government to maintain that cannabis has no medical uses, at the same time as licensing the world’s biggest government-approved medical cannabis production and export market.
“UK patients are either denied access and suffering unnecessarily, or are forced to buy cannabis from the criminal market.
“Countries with proper access to medical cannabis do not have this problem, as standardised cannabis products are in the hands of doctors and pharmacists.”
A significant part of the UK’s legal cannabis production goes towards a cannabis-based medicine called Sativex, produced by GW Pharmaceuticals.
It is available on prescription for patients such as those suffering the effects of multiple sclerosis, but it is only on the NHS in Wales.